Elisabeth Bendstrup

Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Thomas Skovhus Prior
  • Ole Hilberg, Department of Respiratory Medicine, Sygehus Lillabaelt, Vejle, Denmark.
  • ,
  • Saher Burhan Shaker, Herlev and Gentofte University Hospital
  • ,
  • Jesper Rømhild Davidsen, Odense University Hospital, Odense, Denmark.
  • ,
  • Nils Hoyer, Herlev and Gentofte University Hospital
  • ,
  • Surinder S Birring, King's College London School of Medicine, London.
  • ,
  • Elisabeth Bendstrup

BACKGROUND: Health-related quality of life (HRQL) is impaired in patients with idiopathic pulmonary fibrosis (IPF). The King's Brief Interstitial Lung Disease questionnaire (K-BILD) is a validated measure of HRQL, but no previous studies have focused on the validity of K-BILD in IPF. Moreover, the relationship between K-BILD and dyspnoea or the 6-min walk test (6MWT) has not been assessed. The aim of this study was to validate K-BILD in the largest cohort of patients with IPF to date and assess how K-BILD correlates to dyspnoea and 6MWT.

METHODS: Firstly, K-BILD was translated into Danish using validated translation procedures. Consecutive patients with IPF were recruited. At baseline, patients completed K-BILD, the IPF-specific version of St. Georges Respiratory Questionnaire, University of California, San Diego Shortness of Breath Questionnaire (SOBQ) Short Form-36, and pulmonary function tests and 6MWT were performed. After 14 days, K-BILD and Global Rating of Change Scales were completed. Internal consistency, concurrent validity, test-retest reliability and known groups validity were assessed. Analyses were also performed in subgroups of patients with different time since diagnosis.

RESULTS: At baseline, 150 patients with IPF completed the questionnaires, and 139 patients completed the questionnaires after 14 days. K-BILD had a high internal consistency (Cronbach's α = 0.92). The concurrent validity was strong compared to SOBQ (r = - 0.66) and moderate compared to 6MWT (r = 0.43). Intraclass correlation coefficients (ICC = 0.91) and a Bland Altman plot demonstrated a good reliability. K-BILD was also able to discriminate between patients with different stages of disease (p < 0.002, Δscore > 7.4) and most results were comparable in patients with different time since diagnosis.

CONCLUSION: K-BILD is a valid and reliable instrument in patients with IPF and in patients with different time since diagnosis. To a major extent, K-BILD scores reflected the impact of dyspnoea on HRQL and the impact of physical functional capacity measured by the 6MWT to a moderate degree. Compared to PFTs alone, K-BILD provides additional information on the burden of living with IPF, and importantly, K-BILD is simple to implement in both research and clinical contexts.

TRIAL REGISTRATION: Clinicaltrials.org (NCT02818712) on 30 June 2016.

Original languageEnglish
Article number255
JournalBMC Pulmonary Medicine
Number of pages9
Publication statusPublished - Dec 2019

    Research areas

  • Aged, Cohort Studies, Dyspnea/etiology, Female, Humans, Idiopathic Pulmonary Fibrosis/complications, Lung Diseases, Interstitial, Male, Quality of Life, Reproducibility of Results, Respiratory Function Tests, Surveys and Questionnaires, Walk Test

See relations at Aarhus University Citationformats

ID: 207561426